The future of incretins in the treatment of obesity and non-alcoholic fatty liver disease. Andreasen CR, Andersen A, Vilsboll T. Diabetologia 2023;66:1846-1858.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Andreasen CR, Andersen A, Vilsboll T. The future of incretins in the treatment of obesity and non-alcoholic fatty liver disease. Diabetologia 2023;66:1846-1858.
PMID: 37498367